Mesenchymal Stem Cells In Cisplatin-Induced Acute Renal Failure In Patients With Solid Organ Cancers (CIS/MSC08)

Clinical Trial ID NCT01275612

PubWeight™ 12.37^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01275612

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Human embryonic mesenchymal stem cell-derived conditioned medium rescues kidney function in rats with established chronic kidney disease.	PLoS One	2012	1.36
2	Mesenchymal stem cells engineered for cancer therapy.	Adv Drug Deliv Rev	2011	1.26
3	Acute kidney injury following cardiac surgery: current understanding and future directions.	Crit Care	2016	0.99
4	Cell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cells.	Anesthesiology	2014	0.94
5	Mesenchymal stem cells from rats with chronic kidney disease exhibit premature senescence and loss of regenerative potential.	PLoS One	2014	0.91
6	Potential advantages of acute kidney injury management by mesenchymal stem cells.	World J Stem Cells	2014	0.87
7	Expanding role of T cells in acute kidney injury.	Curr Opin Nephrol Hypertens	2014	0.84
8	Mesenchymal Stem Cell-Based Therapy for Kidney Disease: A Review of Clinical Evidence.	Stem Cells Int	2016	0.83
9	Cell-based therapies in kidney disease.	Kidney Int Suppl (2011)	2013	0.81
10	Enabling innovative translational research in acute kidney injury.	Clin Transl Sci	2011	0.81
11	Acute kidney injury: preclinical innovations, challenges, and opportunities for translation.	Can J Kidney Health Dis	2015	0.78
12	Novel surgical techniques, regenerative medicine, tissue engineering and innovative immunosuppression in kidney transplantation.	Arch Med Sci	2016	0.75
13	Autologous Cells for Kidney Bioengineering.	Curr Transplant Rep	2016	0.75
14	Imaging technologies for monitoring the safety, efficacy and mechanisms of action of cell-based regenerative medicine therapies in models of kidney disease.	Eur J Pharmacol	2016	0.75